Harmony Biosciences Holdings (HRMY) Prepaid Assets (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Prepaid Assets of $7.6 million for Q1 2026, down 53.89% on a YoY basis from $16.5 million in Q1 2025, and down 52.57% sequentially from $16.0 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Prepaid Assets (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Prepaid Assets data on file, last reported at $7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 53.89% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 53.89% YoY), and the FY2025 full-year result was $16.0 million, up 16.77% from the prior year.
- Prepaid Assets eased to $7.6 million in Q1 2026, from $16.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $23.3 million in Q3 2025 to a low of $3.7 million in Q2 2022.
- A 5-year average of $10.6 million and a median of $8.8 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 556.07% in 2022 and slumped 53.89% in 2026, its largest moves.
- Tracing HRMY's Prepaid Assets over 5 years: stood at $8.8 million in 2022, then slumped by 36.98% to $5.5 million in 2023, then jumped by 147.68% to $13.7 million in 2024, then rose by 16.77% to $16.0 million in 2025, then slumped by 52.57% to $7.6 million in 2026.
- Business Quant data shows HRMY's Prepaid Assets at $7.6 million in Q1 2026, $16.0 million in Q4 2025, and $23.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.60 Mn |
| Dec 31, 2025 | 16.01 Mn |
| Sep 30, 2025 | 23.31 Mn |
| Jun 30, 2025 | 8.64 Mn |
| Mar 31, 2025 | 16.47 Mn |
| Dec 31, 2024 | 13.71 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 16.13 Mn |
| Mar 31, 2024 | 8.68 Mn |
| Dec 31, 2023 | 5.54 Mn |
| Sep 30, 2023 | 14.27 Mn |
| Jun 30, 2023 | 9.44 Mn |
| Mar 31, 2023 | 6.15 Mn |
| Dec 31, 2022 | 8.79 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 1.56 Mn |